Distinguished in Waldenstrom Macroglobulinemia

Evdoxia Hatjiharissi

Thessaloniki, ESYE12, GR 
Distinguished in Waldenstrom Macroglobulinemia
Thessaloniki, ESYE12, GR 
OverviewLocationsClinical Research

Overview

Evdoxia Hatjiharissi practices in Thessaloniki, Greece. Ms. Hatjiharissi is rated as a Distinguished expert by MediFind in the treatment of Waldenstrom Macroglobulinemia. Her top areas of expertise are Waldenstrom Macroglobulinemia, Multiple Myeloma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 31 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles in the study of Waldenstrom Macroglobulinemia.

Gender
Female

Locations

Thessaloniki, ESYE12, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
Enrollment Status: Active_not_recruiting
Publish Date: March 18, 2025
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pomalidomide, Dexamethasone, Bortezomib
Study Phase: Phase 3

31 Total Publications

Unveiling Extramedullary Myeloma Immune Microenvironment: A Systematic Review.
Unveiling Extramedullary Myeloma Immune Microenvironment: A Systematic Review.
Journal: Cancers
Published: January 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hatjiharissi's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile